SCHEMBL7656090

SCHEMBL7656090

Nc1ccc(Oc2c(F)c(F)c(C(F)(F)F)c(Oc3ccc(C(=O)O)cc3)c2F)cc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
AMY1A P0DUB6 1/20 0.36
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
RXRG P48443 2/20 0.36
NR4A2 P43354 1/20 0.36
SRD5A2 P31213 2/20 0.35
HSD17B10 Q99714 1/20 0.35
AURKA O14965 1/20 0.35
TPX2 Q9ULW0 1/20 0.35
THRB P10828 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8371684 0.90 MMP2 (0.41) HTTHPGDLMNASMN1; SMN2NPC1
SCHEMBL8371687 0.89 LMNA (0.38) HTTHPGDLMNASMN1; SMN2NPC1
SCHEMBL4624402 0.89 MAPT (0.40) SMN1; SMN2RAB9AHSD17B10THRBTSHR
SCHEMBL7658168 0.86 HPGD (0.50) HTTHPGDLMNAPARP15PARP10
SCHEMBL7654088 0.78 PARP10 (0.58) ALDH1A1PARP15PARP10RXRARXRB
SCHEMBL7651725 0.77 HPGD (0.42) HTTHPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL7714315 0.77 MAPT (0.50) HTTHPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL24407671 0.74 HPGD (0.63) HTTHPGDLMNAPARP15PARP10
SCHEMBL4623369 0.73 MAPT (0.41) HTTHPGDLMNASMN1; SMN2NPC1
SCHEMBL4622978 0.73 MAPT (0.46) HTTHPGDLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905170-B1 Polybenzoxazoles and polybenzothiazoles precursors QIMONDA AG (DE) 2013-10-30 EP disclosed
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 US disclosed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 US disclosed
EP-0905123-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 EP disclosed
US-6310238-B1 INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed
EP-0905123-A1 o-amino(thio)phenol-carboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed
EP-0905170-A2 Polybenzoxazoles and polybenzothiazoles precursors SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT HTT 2766/4885HPGD 1718/4885LMNA 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.